Therapy and diagnosis of Alzheimer's disease: from discrete metal complexes to metal–organic frameworks DOI Creative Commons
Amalia García-García, Sara Rojas, Antonio Rodríguez‐Diéguez

et al.

Journal of Materials Chemistry B, Journal Year: 2023, Volume and Issue: 11(30), P. 7024 - 7040

Published: Jan. 1, 2023

Alzheimer's disease (AD) is a neurodegenerative disorder affecting 44 million people worldwide. Although many issues (pathogenesis, genetics, clinical features, and pathological aspects) are still unknown, this characterized by noticeable hallmarks such as the formation of β-amyloid plaques, hyperphosphorylation tau proteins, overproduction reactive oxygen species, reduction acetylcholine levels. There no cure for AD current treatments aimed at regulating cholinesterase levels, attenuating symptoms temporarily rather than preventing progression. In context, coordination compounds regarded promissing tool in treatment and/or diagnosis. Coordination (discrete or polymeric) possess several features that make them an interesting option developing new drugs (good biocompatibility, porosity, synergetic effects ligand-metal, fluorescence, particle size, homogeneity, monodispersity, etc.). This review discusses recent progress development novel discrete metal complexes metal-organic frameworks (MOFs) treatment, diagnosis theragnosis AD. These advanced therapies organized according to target: Aβ peptides, hyperphosphorylated synaptic dysfunction, mitochondrial failure with subsequent oxidative stress.

Language: Английский

Polyacrylic Acid Nanoplatforms: Antimicrobial, Tissue Engineering, and Cancer Theranostic Applications DOI Open Access
Hassan Arkaban, Mahmood Barani, Majid Reza Akbarizadeh

et al.

Polymers, Journal Year: 2022, Volume and Issue: 14(6), P. 1259 - 1259

Published: March 21, 2022

Polyacrylic acid (PAA) is a non-toxic, biocompatible, and biodegradable polymer that gained lots of interest in recent years. PAA nano-derivatives can be obtained by chemical modification carboxyl groups with superior properties comparison to unmodified PAA. For example, nano-particles produced from derivatives used deliver drugs due their stability biocompatibility. its nanoconjugates could also regarded as stimuli-responsive platforms make them ideal for drug delivery antimicrobial applications. These good candidate conventional novel carrier systems. Here, we started synthesis approaches, structure characteristics, other architectures nanoplatforms. Then, different conjugations PAA/nanostructures potential various fields nanomedicine such antimicrobial, anticancer, imaging, biosensor, tissue engineering were discussed. Finally, biocompatibility challenges nanoplatforms highlighted. This review will provide fundamental knowledge current information connected the applications biological broad audience researchers, engineers, newcomers. In this light, have great research development new nano vaccines future.

Language: Английский

Citations

163

Anticancer Drug-Loading Capacity of Green Synthesized Porous Magnetic Iron Nanocarrier and Cytotoxic Effects Against Human Cancer Cell Line DOI
Mohammad Javed Ansari, Saade Abdalkareem Jasim, Talib Zeedan Taban

et al.

Journal of Cluster Science, Journal Year: 2022, Volume and Issue: 34(1), P. 467 - 477

Published: Feb. 9, 2022

Language: Английский

Citations

67

Metal–Organic Frameworks‐Based Nanoplatforms for the Theranostic Applications of Neurological Diseases DOI
Huicong Niu, Hui Bu,

Jing Zhao

et al.

Small, Journal Year: 2023, Volume and Issue: 19(23)

Published: March 12, 2023

Abstract Neurological diseases are the foremost cause of disability and second leading death worldwide. Owing to special microenvironment neural tissues biological characteristics cells, a considerable number neurological disorders currently incurable. In past few years, development nanoplatforms based on metal–organic frameworks (MOFs) has broadened opportunities for offering sensitive diagnosis/monitoring effective therapy neurology‐related diseases. this article, obstacles neurotherapeutics, including delayed diagnosis misdiagnosis, existence blood brain barrier (BBB), off‐target treatment, irrepressible inflammatory storm/oxidative stress, irreversible nerve cell summarized. Correspondingly, MOFs‐based diagnostic/monitoring strategies such as neuroimaging biosensors (electrochemistry, fluorometry, colorimetry, electrochemiluminescence, etc.) therapeutic higher BBB permeability, targeting specific lesion sites, attenuation neuroinflammation/oxidative stress well regeneration extensively highlighted management Finally, challenges present research from perspective clinical translation discussed, hoping facilitate interdisciplinary studies at intersections between neurotheranostics.

Language: Английский

Citations

35

BioMOF-Based Anti-Cancer Drug Delivery Systems DOI Creative Commons
Sandy Elmehrath, Ha L. Nguyen, Sherif M. Karam

et al.

Nanomaterials, Journal Year: 2023, Volume and Issue: 13(5), P. 953 - 953

Published: March 6, 2023

A variety of nanomaterials have been developed specifically for biomedical applications, such as drug delivery in cancer treatment. These materials involve both synthetic and natural nanoparticles nanofibers varying dimensions. The efficacy a system (DDS) depends on its biocompatibility, intrinsic high surface area, interconnected porosity, chemical functionality. Recent advances metal-organic framework (MOF) nanostructures led to the achievement these desirable features. MOFs consist metal ions organic linkers that are assembled different geometries can be produced 0, 1, 2, or 3 defining features their outstanding variable functionality, which enable an endless range modalities loading drugs into hierarchical structures. MOFs, coupled with biocompatibility requisites, now regarded highly successful DDSs treatment diverse diseases. This review aims present development applications based chemically-functionalized MOF context concise overview structure, synthesis, mode action MOF-DDS is provided.

Language: Английский

Citations

34

Environmental implications of metal–organic frameworks and MXenes in biomedical applications: a perspective DOI Creative Commons
Bahareh Farasati Far, Navid Rabiee, Siavash Iravani

et al.

RSC Advances, Journal Year: 2023, Volume and Issue: 13(49), P. 34562 - 34575

Published: Jan. 1, 2023

Metal-organic frameworks (MOFs) and MXenes have demonstrated immense potential for biomedical applications, offering a plethora of advantages. MXenes, in particular, exhibit robust mechanical strength, hydrophilicity, large surface areas, significant light absorption potential, tunable terminations, among other remarkable characteristics. Meanwhile, MOFs possess high porosity area, making them ideal protecting active biomolecules serving as carriers drug delivery, hence their extensive study the field biomedicine. However, akin to (nano)materials, concerns regarding environmental implications persist. The number studies investigating toxicity biocompatibility is growing, albeit further systematic research needed thoroughly understand biosafety issues biological effects prior clinical trials. synthesis often involves use strong acids temperatures, which, if not properly managed, can adverse on environment. Efforts should be made minimize release harmful byproducts ensure proper waste management during production process. In addition, it crucial assess into environment applications. For applications MOFs, several challenges exist. These include fabrication costs, poor selectivity, low capacity, quest stable water-resistant well difficulties recycling/regeneration maintaining chemical/thermal/mechanical stability. Thus, careful consideration associated with utilization vital. addition manufacturing processes, ultimate fate must taken account. While numerous reviews been published this perspective aims shed key issues, urging researchers conduct field. aspects biomedicine are discussed, focusing main outlining future directions.

Language: Английский

Citations

25

Metal-organic frameworks: A promising option for the diagnosis and treatment of Alzheimer's disease DOI
Shima Tajahmadi, Hossein Molavi, Farhad Ahmadijokani

et al.

Journal of Controlled Release, Journal Year: 2022, Volume and Issue: 353, P. 1 - 29

Published: Nov. 21, 2022

Language: Английский

Citations

34

Recent trends in mesoporous silica nanoparticles of rode-like morphology for cancer theranostics: A review DOI
Saman Sargazi, Ushna Laraib, Mahmood Barani

et al.

Journal of Molecular Structure, Journal Year: 2022, Volume and Issue: 1261, P. 132922 - 132922

Published: March 25, 2022

Language: Английский

Citations

32

Advanced nanomaterials for modulating Alzheimer's related amyloid aggregation DOI Creative Commons
Xu Shao, Chaoren Yan, Chao Wang

et al.

Nanoscale Advances, Journal Year: 2022, Volume and Issue: 5(1), P. 46 - 80

Published: Nov. 21, 2022

Alzheimer's disease (AD) is a common neurodegenerative that brings about enormous economic pressure to families and society. Inhibiting abnormal aggregation of Aβ accelerating the dissociation aggregates treated as an effective method prevent treat AD. Recently, nanomaterials have been applied in AD treatment due their excellent physicochemical properties drug activity. As delivery platform or inhibitor, various exhibited potential inhibiting fibrillation, disaggregating, clearing mature amyloid plaques by enhancing performance drugs. This review comprehensively summarizes advantages disadvantages modulating treatment. The design functional discussed, strategies for improved toward are analyzed. Finally, challenges faced with different dimensions AD-related aggregate modulation expounded, prospects proposed.

Language: Английский

Citations

31

Advanced theragnostics for the central nervous system (CNS) and neurological disorders using functional inorganic nanomaterials DOI Creative Commons
Brandon Conklin,

Brian Conley,

Yannan Hou

et al.

Advanced Drug Delivery Reviews, Journal Year: 2022, Volume and Issue: 192, P. 114636 - 114636

Published: Dec. 6, 2022

Language: Английский

Citations

28

Opportunities and challenges of using high-sensitivity nanobiosensors to detect long noncoding RNAs: A preliminary review DOI
Saman Sargazi, Mahwash Mukhtar, Abbas Rahdar

et al.

International Journal of Biological Macromolecules, Journal Year: 2022, Volume and Issue: 205, P. 304 - 315

Published: Feb. 16, 2022

Language: Английский

Citations

24